1/31/2019 | CVLM | Sirius XM receives consents for 1.75% convertible notes due 2023
|
1/31/2019 | CVLM | Sirius extends bid for Pandora’s 2023 convertibles, adds proposed put
|
1/30/2019 | CVLM | Sirius adds one day to consent bid for Pandora’s 2023 convertibles
|
1/28/2019 | CVLM | Sirius gets consents for Pandora’s 2020 notes, extends 2023 bid
|
1/22/2019 | CV | Market Commentary: Intel, Aerojet convertibles active; Pandora better; Arconic contracts on failed buyout
|
1/22/2019 | CV | Market Commentary: Morning Commentary: Intel, Aerojet convertibles active; Pandora improves
|
1/18/2019 | CVLM | Sirius XM launches consent solicitation for Pandora convertibles
|
10/16/2018 | CV | Market Commentary: Evolent Health on tap; Twilio convertibles expand on volatility spike; Pandora improves
|
9/24/2018 | CV | Market Commentary: CenterPoint on tap; Liberty Media convertibles expand; Pandora contracts; Splunk better
|
9/24/2018 | CV | Market Commentary: Morning Commentary: Liberty Media, Pandora convertibles in focus; secondary active
|
5/24/2018 | CVLM | Pandora to swap $192.9 million 2020 convertibles for new 2023 notes, set terms
|
5/24/2018 | CVLM | Pandora to swap $192.9 million of 2020 convertibles for new 2023 notes
|
5/4/2018 | CV | Market Commentary: Five9 and Teladoc hit the market; Gogo, Pandora active; Aceto’s prospects improve
|
6/9/2017 | CV | Market Commentary: Invacare deal comes off of highs; Liberty Expedia’s new issue climbs; BlackRock steady
|
6/9/2017 | CV | Market Commentary: Morning Commentary: Invacare sells new issue; Liberty Expedia deal continues to climb; DISH firms
|
2/7/2017 | CV | Market Commentary: Convertibles little changed in light volume; FXCM crumbles; Zillow quiet ahead of earnings
|
1/13/2017 | CV | Market Commentary: Two Harbors sells upsized deal, trades just over par; Pandora paper rises; SL Green at parity
|
1/6/2017 | CV | Market Commentary: Biotech sector firm, led by Medicines, Ionis; Pandora convertibles in decline; Colony dips
|
1/6/2017 | CV | Market Commentary: Morning Commentary: Biotech sector firm, led by Medicines, Ionis; Pandora convertibles in decline
|
9/13/2016 | CV | Market Commentary: Newer convertibles, balanced names soften; AMD down; Pandora unchanged to better on swap
|
9/13/2016 | CV | Market Commentary: Morning Commentary: AMD trades down with lower shares; Nvidia around triple par; Pandora in focus
|
7/22/2016 | CV | Market Commentary: New Blackhawk trades up 2 points on swap; Pandora treads water as stock reverses course
|
7/21/2016 | CV | Market Commentary: New Belden jumps on debut; Blackhawk on tap; Intel edges up on swap; Proofpoint shares up
|
7/19/2016 | CV | Market Commentary: Convertibles trade quietly amid mixed stocks; Medicines lower with shares; Intel eyed
|
7/18/2016 | CV | Market Commentary: Convertibles firm; Herbalife slips back to unchanged mark; Weatherford a little lower
|
5/17/2016 | CV | Market Commentary: Allegheny Technologies launches new deal; Pandora eyed after activist investors urge sales
|
4/29/2016 | CV | Market Commentary: New Knowles adds on swap; Molina drops outright, adds on swap; TiVo, Pandora improve
|
3/28/2016 | CV | Market Commentary: Yahoo! convertibles higher on swap; convertibles overall thinly traded after holiday
|
2/11/2016 | CV | Market Commentary: Convertibles lag after crude oil, equities pare sharp losses; Monster Worldwide plunges
|
12/31/2015 | CV | Outlook 2016: Modest convertible returns expected, but vol. should boost valuations; rates eyed
|
12/31/2015 | CV | Market Commentary: Outlook 2016: Convertibles primary market seen in line to higher after disappointing 2015
|
12/17/2015 | CV | Market Commentary: Convertibles improve after Fed raises rates; Pandora gains after ruling; Navistar lower
|
12/17/2015 | CV | Market Commentary: Morning Commentary: Convertibles leveling off after strong start; Pandora up 1.5 points to 2 points
|
12/9/2015 | CV | Pandora greenshoe fully exercised, lifts convertibles to $345 million
|
12/7/2015 | CV | Market Commentary: Convertibles soft as energy lags; Chesapeake weaker; Whiting down; Harmonic notes on tap
|
12/4/2015 | CV | Market Commentary: Pandora busy, gyrating post-pricing; Vitamin Shoppe subdued; Kinder’s preferreds decline
|
12/4/2015 | CV | Market Commentary: Morning Commentary: Pandora busy, gyrating post-pricing; Vitamin Shoppe subdued; Kinder declines
|
12/4/2015 | CV | New Issue: Pandora Media sells $300 million five-year convertible notes to yield 1.75%, up 30%
|
12/3/2015 | CV | Market Commentary: Teva contracts on swap; new Inphi adds 0.5 point; Pandora, Vitamin Shoppe deals look cheap
|
12/3/2015 | CV | Market Commentary: Morning Commentary: New Teva lags; Inphi trades better; Pandora, Vitamin Shoppe deals look cheap
|
12/2/2015 | CV | Market Commentary: Upsized Nuance edges up in trade; planned Inphi looks cheap; Teva on tap; Pandora launches
|
12/2/2015 | CV | Pandora plans to price $300 million five-year convertibles to yield 1.75%-2.25%, up 25%-30%
|